Waters Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Waters stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
View analyst ratings for Waters or view top-rated stocks.

Wall Street analysts have given Waters a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Waters wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Waters saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 1,310,000 shares, an increase of 31.3% from the June 15th total of 997,400 shares. Based on an average daily trading volume, of 406,500 shares, the short-interest ratio is presently 3.2 days. Approximately 2.1% of the shares of the stock are sold short.
View Waters' Short Interest.

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Waters.

Waters Co. (NYSE:WAT) posted its earnings results on Tuesday, August, 3rd. The medical instruments supplier reported $2.60 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.29 by $0.31. The medical instruments supplier earned $681.70 million during the quarter, compared to the consensus estimate of $625.36 million. Waters had a trailing twelve-month return on equity of 1,107.70% and a net margin of 24.56%. Waters's revenue for the quarter was up 31.1% on a year-over-year basis. During the same period last year, the firm earned $2.10 earnings per share.
View Waters' earnings history.

Waters' stock was trading at $184.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WAT stock has increased by 112.8% and is now trading at $391.75.
View which stocks have been most impacted by COVID-19.

Waters issued an update on its FY21 earnings guidance on Tuesday, August, 3rd. The company provided EPS guidance of $10.560-10.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.15.

8 equities research analysts have issued 1 year target prices for Waters' stock. Their forecasts range from $185.00 to $400.00. On average, they anticipate Waters' share price to reach $271.25 in the next year. This suggests that the stock has a possible downside of 30.8%.
View analysts' price targets for Waters or view top-rated stocks among Wall Street analysts.

13 employees have rated Waters CEO Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among Waters' employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of WAT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Raytheon Technologies (RTX), CVS Health (CVS), The Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Marathon Asset Management LLP (0.70%), Boston Trust Walden Corp (0.55%), Beck Mack & Oliver LLC (0.45%), Sumitomo Mitsui Trust Holdings Inc. (0.44%), Bristol John W & Co. Inc. NY (0.42%) and PGGM Investments (0.26%). Company insiders that own Waters stock include Christopher J Oconnell, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Linda Baddour, Mark T Beaudouin, Michael C Harrington, Michael J Berendt, Robert G Carson and Sherry Buck.
View institutional ownership trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Mondrian Investment Partners LTD, Boston Trust Walden Corp, Unigestion Holding SA, Boston Financial Mangement LLC, New York State Common Retirement Fund, Baillie Gifford & Co., Alliancebernstein L.P., and Bristol John W & Co. Inc. NY. Company insiders that have sold Waters company stock in the last year include Edward Conard, Ian King, Joann A Reed, Linda Baddour, Michael C Harrington, Michael J Berendt, Robert G Carson, and Sherry Buck.
View insider buying and selling activity for Waters or view top insider-selling stocks.

WAT stock was purchased by a variety of institutional investors in the last quarter, including Marathon Asset Management LLP, Sumitomo Mitsui Trust Holdings Inc., Handelsbanken Fonder AB, LaFleur & Godfrey LLC, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Tuttle Tactical Management, and Marshall Financial Group LLC.
View insider buying and selling activity for Waters or or view top insider-buying stocks.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WAT stock can currently be purchased for approximately $391.75.

Waters has a market capitalization of $24.17 billion and generates $2.37 billion in revenue each year. The medical instruments supplier earns $521.57 million in net income (profit) each year or $9.05 on an earnings per share basis.

Waters employs 7,400 workers across the globe.

The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).

Waters was founded in 1958.

The official website for Waters is www.waters.com.

Waters is headquartered at 34 MAPLE STREET, MILFORD MA, 01757.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]